About LongeVC
LongeVC is a Financial Services company based in Washington D.C., United States. LongeVC is focused on venture capital investments in biotech. It operates on a Commission-Based model. LongeVC offers products and services including Venture Capital Investment. Its focus areas include Financials, Venture Capital and Biotech Investment.
Company details
LongeVC is engaged in venture capital investments targeting early-stage biotech and longevity-focused companies. Support is provided to founders in pre-clinical and clinical stage drug development, personalized medicine, advanced diagnostics, and foundational platform technologies. The firm is dedicated to building an ecosystem that connects innovators with global thought leaders to advance solutions for an ageless future. Sectors covered include therapeutics, diagnostics, prevention, and longevity infrastructure, with an emphasis on transforming health through breakthrough science.
- Headquarters Washington D.C., United States
- SectorsFinancial Services
- Email••••••••
- Website longevc.com
- Social LinkedIn X
Products & Services of LongeVC
LongeVC offers a comprehensive portfolio of products and services, including Venture Capital Investment.
Investments are made in early-stage biotech companies.
People of LongeVC
18 people are tracked at LongeVC (6 in leadership, 11 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Garri Zmudze | Managing Partner | Leadership |
Sergey Jakimov | Managing Partner | Leadership |
Ilya Suharenko | Managing Partner | Leadership |
Konstantinos Maitos | Chief Financial Officer | Leadership |
Greg Fishman | Venture Partner | Leadership |
Toms Sturitis | Chief Operating Officer | Leadership |
Alex Zhavoronkov | Head of Advisory Board | Board & advisors |
Luis Angel | Advisor | Board & advisors |
Tzipi Strauss | Advisor | Board & advisors |
Michael Levitt | Advisor | Board & advisors |
Evelyne Bischof | Advisor | Board & advisors |
Mike Martin | Advisor | Board & advisors |
Matt Kaeberlein | Advisor | Board & advisors |
Vadim Gladyshev | Advisor | Board & advisors |
Miro Venturi | Advisor | Board & advisors |
Evgeny Izumchenko | Advisor | Board & advisors |
Alexey Moskalev | Advisor | Board & advisors |
Vlad Cernoutan | Unknown Role | Team |
Complete people profiles for LongeVC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Top companies in Venture Capital Funds
3 companies that operate in the same segment as LongeVC (Venture Capital Funds), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Venture capital firm investing in early-stage tech startups | 1972 | Menlo Park, California, United States | ||||
Venture capital investments and support for entrepreneurs in technology and innovation sectors. | 1911 | Redwood City, California, United States | USD 691.23 K | |||
Accel is recognized as a leading venture capital firm. | 1983 | Palo Alto, California, United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LongeVC
LongeVC is engaged in venture capital investments targeting early-stage biotech and longevity-focused companies. Support is provided to founders in pre-clinical and clinical stage drug development, personalized medicine, advanced diagnostics, and foundational platform technologies. The firm is dedicated to building an ecosystem that connects innovators with global thought leaders to advance solutions for an ageless future. Sectors covered include therapeutics, diagnostics, prevention, and longevity infrastructure, with an emphasis on transforming health through breakthrough science.
LongeVC offers Venture Capital Investment.